Halifax Biomedical specializes in enhancing the safety and performance of orthopedic implants through its proprietary Radiostereometric Analysis (RSA) imaging solution. This advanced technology allows for precise validation of implant safety, ensuring that products meet the highest standards and facilitating expedited regulatory approvals. By leveraging RSA technology, Halifax Biomedical aims to mitigate risks associated with orthopedic implants, ultimately prioritizing patient safety and improving overall healthcare outcomes.

The company is committed to pioneering innovations in RSA technology, collaborating closely with healthcare providers, including surgeons and hospitals. This partnership approach enables Halifax Biomedical to offer sustained monitoring and thorough analysis of implant performance, which is crucial for independent safety validation. Their framework of Phased Innovation not only accelerates research but also limits risks, thereby protecting patients and enhancing the overall effectiveness of orthopedic treatments.

Canada

HALIFAX BIOMEDICAL INC. (HBI) is a biomedical company focused on the delivery of contract research services and the development of diagnostic medical equipment.

We are the only company worldwide currently providing a complete product and service solution for RSA. We support the fundamental principles of phased innovation - the practice of clinically testing products before general market release.

Halifax Biomedical

Company Details